Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/21/22 → 10/9/23 |
Funding
- Lung Biotechnology PBC: $13,275.00
PERFECT PH COPD: A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients with Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease
- Smith, Jimmy (PI)